The use of financial incentives in promoting smoking cessation
- PMID: 22525802
- PMCID: PMC3411852
- DOI: 10.1016/j.ypmed.2012.04.007
The use of financial incentives in promoting smoking cessation
Abstract
Objective: Cigarette smoking is the leading cause of preventable death in the United States and world. Despite the availability of numerous therapies for smoking cessation, additional efficacious interventions are greatly needed. We provide a narrative review of published studies evaluating financial incentives for smoking cessation and discuss the parameters important for ensuring the efficacy of incentive interventions for smoking cessation.
Methods: Published studies that evaluated the impact of incentives to promote smoking cessation and included an appropriate control or comparison condition were identified and reviewed.
Results: Incentives are efficacious for promoting smoking abstinence across the general population of smokers as well as substance abusers, adolescents, patients with pulmonary disease, patients with serious mental illness and other challenging subgroups. To develop and implement an effective incentive treatment for smoking, special attention should be paid to biochemical verification of smoking status, incentive magnitude and the schedule of incentive delivery.
Conclusion: Consistent with the extensive literature showing that incentives are effective in reducing illicit drug use, a large body of evidence supports their effectiveness in reducing smoking. Continued efforts are warranted to further develop and disseminate incentive-based treatments for smoking cessation across clinical settings and populations.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
References
-
- Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:367–370. - PubMed
-
- Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, Mayo MS. Sustained release bupropion for smoking cessation in african americans. JAMA. 2002;288:468–474. - PubMed
-
- Alessi SM, Badger GJ, Higgins ST. An experimental examination of the initial weeks of abstinence in cigarette smokers. Exp Clin Psychopharmacol. 2004;12:276–287. - PubMed
-
- Amass L, Bickel WK, Crean J, Higgins ST, Badger GJ. Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program. J Subst Abuse Treat. 1996;13:43–49. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
